Background. Data on the natural history of human papillomavirus (HPV)–related genital
warts (GWs) in men are sparse. We described the distribution of HPV types in incident GWs …

Objectives To evaluate the relationship of warts in different parts of the body and the risk of
asymptomatic genital human papillomavirus (HPV) infection in men. Methods We examined …

Background. Although human immunodeficiency virus (HIV)–negative men having sex with
men (MSM) bear a substantial burden of human papillomavirus (HPV)–associated disease …

Determining the rate at which men develop genital warts after infection with alpha genus
human papillomavirus (HPV) types will provide important information for the design of …

Background. We report the first nationally representative prevalence data on genital human
papillomavirus (HPV) in males in the United States, using findings from the National Health …

Background. More than 90% of genital warts (GW) cases are caused by human
papillomavirus (HPV) types 6 and 11. The introduction of HPV vaccines necessitates the …

Background We conducted a large national cohort study to examine the risk of cancer
among men and women with genital warts (GW). Methods By use of the Danish National …

Background. Diagnoses of genital warts (GW) in genitourinary medicine (GUM) clinics have
been increasing in England for many years. In 2008, an HPV immunization program began …

Background Genital warts are important causes of morbidity and their prevalence and
incidence can be used to evaluate the impact of HPV vaccination in a population. Methods …

Background A quadrivalent vaccine that prevents genital warts (GWs) has been
recommended by the Advisory Committee on Immunization Practices for women since 2007 …